Highlight
- MRD testing stratifies AML patients in remission by relapse risk post-allogeneic HCT.
- MRD guides decisions on transplantation eligibility, conditioning regimen intensity, and post-transplant surveillance.
- Emerging MRD-based interventions include post-transplant maintenance and pre-emptive therapy to reduce relapse.
- Clinicians face challenges interpreting MRD results amid evolving methodologies and incomplete standardization.
